Examiner: PAK, MICHAEL D

Tech Center 1600 • Art Units: 1644 1646 1674 1682

This examiner grants 58% of resolved cases

Performance Statistics

58.5%

Allow Rate

-1.5% vs TC avg

732

Total Applications

+30.3%

Interview Lift

1362

Avg Prosecution Days

Based on 704 resolved cases, 2023–2026

7.9%

§101 Eligibility

21.6%

§102 Novelty

22.1%

§103 Obviousness

36.5%

§112 Clarity

App #	Title	Status	Assignee
17860453	Manufacturing Methods for Producing Anti-IL12/IL23 Antibody Compositions	Non-Final OA	Janssen Biotech, Inc.
17410658	THE FGF19-CHOLESTYRAMINE (F-CME) TEST AS A TWO-STAGE METHOD FOR ROUTINE CANCER SCREENING	Final Rejection	UNIVERSITY OF CENTRAL FLORIDA RESEARCH FOUNDATION, INC.
18034289	ANTIGEN BINDING MOLECULES AND USES THEREOF	Non-Final OA	Agency for Science, Technology and Research

IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.